Clinical Trials
6 trialsNCT06833073 2026-05-28
INTerpath-011
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT05951179 2026-05-18
ADVANCED-2
Protara Therapeutics
Phase 2 Recruiting
NCT04752722 2026-04-30
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
enGene, Inc.
Phase 1/2 Recruiting
NCT07283835 2026-04-23
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Lepu Biopharma Co., Ltd.
Phase 2 Recruiting
NCT07480356 2026-03-18
ADVANCED-3
Protara Therapeutics
Phase 3 Not yet recruiting
NCT04452591 2026-03-16
BOND-003
CG Oncology, Inc.
Phase 3 Active not recruiting